03 October 2022

For the first time, the Bellvitge Hospital (HUB) is one of the stops of the Innobus, a programme of the Innovation and Knowledge Agency of Baix Llobregat and Hospitalet (Innobaix) and the Metropolitan Area of Barcelona. For fifteen days, the bus visits leading companies and institutions of the area with the aim of delivering fresh ideas to innovation challenges. On Monday 3 October, the Innobaixers visited the HUB facilities to propose solutions that could have an impact on the citizens’ health.

28 September 2022

Throughout the week of October 3rd to 8th, gymkhanas, talks, visits, and many other activities will bring science from the Bellvitge Campus closer to the public.

On Saturday, activities for all ages on the Open Day will end with a great party.

Seven scientific monologues from the Stand-up Science series, three research capsules Quinaciència! and four Tapas of Innovation will be released in the sinergia.l-h.cat website.

22 September 2022

The use of fluorescence in thyroidectomy significantly reduces the risk of affecting the parathyroid glands, which regulate calcium in the human body.

The HUB's Endocrine Surgery Unit is a benchmark in minimally invasive thyroid surgery.

22 September 2022
The Respiratory Endoscopy Unit of the Pneumology Service at the Bellvitge University Hospital (HUB) has performed this September for the first time a procedure called CRYOEBUS (transbronchial mediastinal cryobiopsy guided by endobronchial ultrasound), which combines endobronchial ultrasound and cryobiopsy in order to improve the diagnosis of lung tumours, lymphomas and other diseases located in the mediastinum.
19 September 2022
Drs Josep Comin and Pedro Moliner, members of the HUB’s Heart Failure Multidisciplinary Unit and researchers at IDIBEL’s Bioheart group, have been invited to publish in Nature Reviews Cardiology, the scientific cardiology journal with the highest impact factor. Specifically, they have written a review on intravenous iron supplementation in patients with chronic heart failure.
19 September 2022

The Innobaix Association and the ICS’s Southern Metropolitan Territorial Management of have signed a collaboration agreement with the common aim of encouraging and promoting innovation in the field of health.

The agreement was signed by Lluís Bahamonde, president of Innobaix, and Dr Montserrat Figuerola, territorial manager of the South Metropolitan Area.